Nw. Milgram et al., THE EFFECT OF L-DEPRENYL ON BEHAVIOR, COGNITIVE FUNCTION, AND BIOGENIC-AMINES IN THE DOG, Neurochemical research, 18(12), 1993, pp. 1211-1219
Behavioral and pharmacological effects of oral administration of L-dep
renyl in the dog are described. Spontaneous behavior is unaffected at
doses below 3 mg/kg while at higher doses there was stereotypical resp
onding. There was evidence of improved cognitive function in animals c
hronically treated with a 1 mg/kg dose but the effectiveness varied co
nsiderably between subjects. Chronic administration produced a dose de
pendent inhibition in brain, kidney and liver monoamine oxidase B, and
had no effect on monoamine oxidase A. There were also dose dependent
increases in brain phenylethylamine and in plasma levels of amphetamin
e. Dog platelets did not have significant levels of MAO-B. Brain dopam
ine and serotonin metabolism were unaffected by L-deprenyl at doses up
to 1 mg/kg. It appears that for the dog, deamination of catecholamine
s is controlled by MAO-A. Nevertheless, it is suggested that L-depreny
l serves as a dopaminergic agonist, and there is also evidence that it
affects adrenergic transmission. These catecholaminergic actions may
account for the effects Of L-deprenyl on behavior and cognitive functi
on.